Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2023-11-02 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 2470S' and concludes with text stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'TR-1: Standard form for notification of major holdings' regarding an acquisition/disposal of voting rights by UBS Group AG. This type of mandatory disclosure concerning changes in significant share ownership thresholds fits the definition of Major Shareholding Notification (MRQ). It is not a full financial report (10-K, IR) or a general announcement (RNS), but a specific regulatory filing type related to ownership changes.
2023-11-02 English
Form 8.3 - Dechra Pharmaceuticals plc
M&A Activity Classification · 98% confidence The document is explicitly titled 'FORM 8.3 - Dechra Pharmaceuticals plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure by a person with interests in relevant securities representing 1% or more, specifically in the context of an offer (takeover activity). This directly relates to M&A Activity (TAR) or insider dealing/ownership changes during a takeover scenario. Since the core content details positions and dealings related to an offer for Dechra Pharmaceuticals plc, it falls under the scope of takeover/merger activity, which aligns best with the 'M&A Activity (Code: TAR)' definition, as it is a mandatory disclosure during a takeover process. It is not a general Director's Dealing (DIRS) as it is triggered by the Takeover Code rules related to an offer.
2023-11-02 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled as an 'RNS Number' notification from 'Dechra Pharmaceuticals PLC' dated '02 November 2023'. The form title is 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) by an entity (Societe Generale in this case). This directly corresponds to the definition of 'Major Shareholding Notification' (Code: MRQ). Although it is distributed via RNS, the specific content is a major holding notification, making MRQ the most precise classification over the general RNS fallback.
2023-11-02 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as originating from 'RNS Number : 0907S' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in major shareholdings (insider/significant shareholder transactions). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the content itself is a specific regulatory disclosure about share ownership changes, making MRQ the most precise classification over the general RNS fallback.
2023-11-01 English
Form 8.3 - Dechra Pharmaceuticals plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled "FORM 8.3 - Dechra Pharmaceuticals plc" and contains the header "PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)". This form relates to disclosures required under the UK Takeover Code, specifically concerning interests or dealings in securities during a takeover situation. This type of filing, which reports insider/major shareholder transactions related to a specific corporate action (takeover), is most closely aligned with Director's Dealing (DIRS) or a specific regulatory filing. Since it details personal share transactions/interests by a major holder (Millennium International Management LP) in the context of a potential takeover, it falls under the scope of insider/director dealing disclosures, even though it's a specific Takeover Code form rather than a standard DIRS filing. However, given the provided categories, 'Director's Dealing' (DIRS) is the closest fit for reporting personal security transactions by an interested party, although it is technically a Takeover Code disclosure. Since it is a specific regulatory disclosure about security holdings/dealings, and not a general announcement (RNS) or a remuneration report (DEF 14A), DIRS is the most appropriate classification for reporting security transactions by an interested party.
2023-11-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with "RNS Number : 0880S" and contains standard regulatory disclosure sections like "TR-1: Standard form for notification of major holdings". This form is used to report changes in major shareholdings, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing about share ownership changes, making MRQ the most precise classification over the general RNS fallback.
2023-11-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.